LAVA Therapeutics N.V. (LVTX)
$1.74+0.00%Close
BUYBULL · day 27
Key stats
- Market cap
- $46M
- Beta
- 0.50
- P/E (TTM)
- -2.95
- 1W
- +0.00%
- 1M
- +8.07%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- +5.08%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on LVTX?
- LOPJLB’s latest quantitative signal on LAVA Therapeutics N.V. (LVTX) is BUY in a BULL regime. Signals are updated daily.
- What market regime is LVTX in?
- LAVA Therapeutics N.V. (LVTX) is currently classified in the BULL HMM market regime on LOPJLB.
- What does LAVA Therapeutics N.V. (LVTX) do?
- LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a …